News

Polya Braykova, PharmD successfully graduates the CIS Research Pharmacy Fellowship Program at Gurnee, IL Clinic FOR IMMEDIATE RELEASE Gurnee, IL – Clinical Investigation Specialists, Inc. congratulates 2025 Pharmacy Fellowship Program Graduate Polya Braykova, PharmD on her successful completion of the program. In 2024, Polya graduated from Midwestern University College of Pharmacy where she was recognized on the Dean’s List for outstanding academic performance for ten quarters. Regarding her experience as a pharmacy fellow, Polya says: “Completing the Clinical Research Fellowship at CIS has ...

CIS Research is proud to announce our WCBRB Award and certification as one of the top businesses in America. March 20, 2025 | For Immediate Release CIS Communications CIS Research is proud to announce that we have received the Worldwide Certified Business Review Board (WCBRB) Best Business Award for “Best Research Center in Gurnee, IL” for “consumer satisfaction, outstanding service, business leadership, strong vision.” We have also received WCBRB verification. As part of this recognition, Clinical Investigation Specialists received a certification to be displayed in our Gurnee clinic and have ...

Renowned GI Specialist Brings Decades of Clinical Expertise and Research Leadership. FOR IMMEDIATE RELEASE Des Plaines, IL – Clinical Investigation Specialists (CIS) proudly announces the addition of Dr. Mani Mahdavian, MD, as an Affiliate Principal Investigator specializing in Gastroenterology. Dr. Mahdavian brings over 25 years of clinical experience and a distinguished record in advanced gastrointestinal procedures and research. Board-certified in both Gastroenterology and Internal Medicine, Dr. Mahdavian is renowned for his expertise in endoscopic ultrasound and the treatment of pancreatic ...

President and Director of Clinical & Regulatory Affairs, Dr. Eva Agaiby, leads groundbreaking research at Clinical Investigation Specialists, Inc. FOR IMMEDIATE RELEASE Gurnee, IL- CIS Research is pleased to announce our pivotal contributions to clinical trials advancing FDA-approved treatment for patients with diabetes and obesity. Under the leadership of our President and Director of Clinical & Regulatory Affairs, Eva Agaiby, PharmD, CIS Research is continually positioned at the forefront of innovative healthcare solutions. Clinical Investigation Specialists, Inc. has been honored to ...

Trusted Rheumatologist Contributes Expertise to Support Patients Navigating Lupus and Lupus Nephritis FOR IMMEDIATE RELEASE Skokie, IL – Clinical Investigation Specialists, Inc. (CIS Research) is pleased to announce that Dr. Robert A. Hozman, MD, F.A.C.R., a leading rheumatologist with decades of experience treating autoimmune diseases, is collaborating with MyDoc to expand educational outreach for patients living with lupus and lupus nephritis. The partnership features Dr. Hozman as a key medical contributor to the MyDoc digital magazine, an initiative designed to help patients and caregivers ...

Online discourse surrounding GLP-1 medications (such as semaglutide) has exploded in popularity across social media and news outlets. As clinical research continues and these medications become increasingly accessible for patients, it is important to understand what they are and how they work in the body. What is semaglutide? What is it used for and how does it work? Semaglutide mimics a natural hormone called GLP-1 (glucagon-like peptide-1). It was originally developed for type 2 diabetes. It’s now also used for weight management and is under study for other conditions. What is GLP-1? GLP-1 ...

Clinical Investigation Specialists, Inc. (CIS Research) is celebrating fourteen years of Better Business Bureau Accreditation! We are proud to have an A+ rating on the BBB website with over a twenty-five-year-long track record of providing excellent patient care. Visit our page on the Better Business Bureau here. Clinical Investigation Specialists | BBB Business Profile | Better Business Bureau October 10, 2024

Clinical Investigation Specialists, Inc. is pleased to announce a new digital community outreach strategy leveraging social media. CIS Research's Marketing team created new company social media accounts on TikTok, Instagram, and YouTube earlier this year after devising a strategic plan for increased reach and brand awareness online. "While CIS Research had active accounts on Facebook and LinkedIn for many years, we've become increasingly aware of the power of newer social platforms as clinical trial recruitment channels", says Business Manager Allen Banoub, MBA. "The data says that patients ...